Restasis 0.05% eye emulsion 30S
Ended Awarded
- Contract number
- SPE2DR26FZ67S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,705
Award facts
- Contract value 100% obligated
- $2,705.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,705.40 to AmerisourceBergen Drug Corp for the supply of Restasis 0.05% eye emulsion (30 single-use containers) on November 12, 2025, with completion scheduled for November 13, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a small-value pharmaceutical transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive IDC vehicle that enables delivery of a broad range of pharmaceutical products and medical supplies to military and veteran healthcare systems worldwide. The company's federal contract portfolio demonstrates significant capability in fulfilling diverse medical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Restasis, a prescription ophthalmic emulsion, exemplifies the company's ongoing role in supporting the Defense Health Agency and broader Department of Defense healthcare operations through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FZ67S?
SPE2DR26FZ67S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FZ67S worth?
The government has obligated $2,705 on SPE2DR26FZ67S.
Is contract SPE2DR26FZ67S an order under another contract?
Yes. SPE2DR26FZ67S is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ67S competed?
The extent of competition for SPE2DR26FZ67S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award